The prevalence of psychotropic medication consumption was assessed in the UK by surveying a representative sample of 4972 non-institutionalized individuals 15 years of age or older (participation rate, 79.6%). A questionnaire was administered over the telephone with the help of the Sleep-Eval Expert System.
Topics covered included : type and name of medication, indication, dosage, duration of intake, and medical specialty of prescriber.
Also collected were data pertaining to sociodemographics, physical illnesses, and DSM-IV mental disorders.
Overall, 3.5% [95% CI : 3-41 of the sample reported current use of psychotropic medication.
Consumption was higher among women (4.6%) [1.8-5.4]) than men (2.3%) [1.7-2.9]), and among the elderly (=65 years of age).
The distribution of psychotropics was :
Hypnotics 1.5%, antidepressants 1.1%, and anxiolytics 0.8%. The median duration of psychotropic intake was 52 weeks.
General practitioners were the most common prescribers of psychotropics (over 80% for each class of drug).
Nearly half the antidepressant users were diagnosed by the system with a DSM-IV anxiety disorder, and one-fifth the anxiolytic users with a depressive disorder.
A marked improvement in sleep quality was reported by half the subjects using a psychotropic for sleep-enhancing purposes.
Psychotropic users were more likely than non-users to report episodes of memory loss, vertigo, or anomia. (...)
Mots-clés Pascal : Hypnotique, Antidépresseur, Neuroleptique, Psychotrope, Indication, Posologie, Durée, Epidémiologie, Chimiothérapie, Traitement, Prévalence, Homme, Royaume Uni, Europe
Mots-clés Pascal anglais : Hypnotic, Antidepressant agent, Neuroleptic, Psychotropic, Indication, Posology, Duration, Epidemiology, Chemotherapy, Treatment, Prevalence, Human, United Kingdom, Europe
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0222709
Code Inist : 002B02B11. Création : 11/09/1998.